# ARL6IP5 in cancers: bidirectional function and therapeutic value

## TL;DR

This paper reviews the role of ARL6IP5 in cancers, highlighting its mixed effects and potential for cancer therapy.

## Contribution

The paper provides a summary of ARL6IP5's bidirectional role in cancer progression and its therapeutic potential.

## Key findings

- ARL6IP5 has both tumor-promoting and tumor-suppressing roles in different cancers.
- It plays a significant role in chronic hepatitis virus-related hepatocellular carcinoma progression.
- ARL6IP5 shows potential as a target for cancer therapy.

## Abstract

ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5) plays an important role in a variety of physiological or pathological processes, including in cancers. However, the biological roles of ARL6IP5 in cancers are controversial. In this mini-review, we summarized the current understanding on the role of ARL6IP5 in cancers, particularly in the progression of chronic hepatitis virus-related hepatocellular carcinoma, as well as the potential values of ARL6IP5 in cancer therapy.